Aavanira Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 05-01-2025
- Paid Up Capital ₹ 0.10 M
as on 05-01-2025
- Company Age 14 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.33 Cr
as on 05-01-2025
- Revenue 40.59%
(FY 2022)
- Profit 542.57%
(FY 2022)
- Ebitda 12.45%
(FY 2022)
- Net Worth 23.74%
(FY 2022)
- Total Assets 1.41%
(FY 2022)
About Aavanira Biotech
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.33 Cr.
Bikash Aich, Ajit Aich, and Shibani Aich serve as directors at the Company.
- CIN/LLPIN
U74900PN2010PTC137544
- Company No.
137544
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Oct 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Aavanira Biotech Private Limited offer?
Aavanira Biotech Private Limited offers a wide range of products and services, including Catering Services, Meal Services, Agricultural & Farm Consultants, Agricultural Testing Service, Pollution Control Services, Pharmaceutical Services, Pharmaceutical Testing Services, Testing & Measuring Equipments, Water Testing Kits, Environment Protection & Auditing.
Who are the key members and board of directors at Aavanira Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bikash Aich  | Managing Director | 14-Oct-2010 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ajit Aich | Director | 14-Oct-2010 | Current |
| Shibani Aich | Director | 26-Mar-2022 | Current |
Financial Performance of Aavanira Biotech.
Aavanira Biotech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 40.59% increase. The company also saw a substantial improvement in profitability, with a 542.57% increase in profit. The company's net worth Soared by an impressive increase of 23.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aavanira Biotech?
In 2021, Aavanira Biotech had a promoter holding of 88.50% and a public holding of 11.50%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Aavanira Technologies Private LimitedActive 4 years 2 monthsBikash Aich and Shibani Aich are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 27 Mar 2024 | ₹2.69 M | Open |
Others Creation Date: 05 Jun 2023 | ₹6.00 M | Open |
Others Creation Date: 20 Apr 2012 | ₹7.00 M | Open |
How Many Employees Work at Aavanira Biotech?
Aavanira Biotech has a workforce of 15 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aavanira Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aavanira Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
